Quantitative CT Analysis Using Caliper Identifies Vessel Volume as a Predictor of FVC Decline in Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone

被引：0
|
作者：
Thillai, M. [1 ]
Swietlik, E. [1 ]
Ruggiero, A. [1 ]
McLellan, T. [1 ]
机构：
[1] ILD Unit, Cambridge, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2400
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Analysis and review of patients with idiopathic pulmonary fibrosis treated with pirfenidone
    Valle Corpas, Margarita
    Casas Hidalgo, Inmaculada
    Rodriguez Delgado, Alejandro
    Moreno Raya, Patricia
    Moron Romero, Rocio
    Gonzalez Medina, Maria del Carmen
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 333 - 334
  • [2] CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis
    Iwasawa, Tae
    Ogura, Takashi
    Sakai, Fumikazu
    Kanauchi, Tetsu
    Komagata, Takanobu
    Baba, Tomohisa
    Gotoh, Toshiyuki
    Morita, Satoshi
    Yazawa, Takuya
    Inoue, Tomio
    EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (01) : 32 - 38
  • [3] Comment on: CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis
    Rea, Gaetano
    Bocchino, Marialuisa
    EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (10) : 1988 - 1989
  • [4] Reply to: Comment on: CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis
    不详
    EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (10) : 1990 - 1990
  • [5] AUTOMATED MEASURED CT LUNG VOLUME CORRELATED WITH FVC IN IDIOPATHIC PULMONARY FIBROSIS
    Jo, Woori
    Lim, Soyeoun
    Seo, Kwang Won
    Bae, Soohyun
    Kim, Jin Hyoung
    Kang, Byung Ju
    Jegal, Yangjin
    CHEST, 2019, 156 (04) : 1703A - 1703A
  • [6] Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone
    Majek, Ondrej
    Gregor, Jakub
    Mogulkoc, Nesrin
    Lewandowska, Katarzyna
    Sterclova, Martina
    Muller, Veronika
    Hajkova, Marta
    Kramer, Mordechai R.
    Tekavec-Trkanjec, Jasna
    Jovanovic, Dragana
    Studnicka, Michael
    Stoeva, Natalia
    Kirchgassler, Klaus-Uwe
    Littnerova, Simona
    Dusek, Ladislav
    Vasakova, Martina Koziar
    PLOS ONE, 2022, 17 (09):
  • [7] ANNUAL RATE OF FVC DECLINE IN VARIOUS PATIENT SUB-GROUPS WITH IDIOPATHIC PULMONARY FIBROSIS TREATED WITH PIRFENIDONE: POOLED ANALYSIS FROM 3 PIVOTAL STUDIES
    Noble, P. W.
    Albera, C.
    Chou, W.
    Costabel, U.
    Day, B.
    Glaspole, I.
    Glassberg, M. K.
    Lancaster, L.
    Lederer, D. J.
    Nathan, S. D.
    Pereira, C. A.
    Stauffer, J.
    Swigris, J. J.
    THORAX, 2016, 71 : A57 - A57
  • [8] Analysis of patients with idiopathic pulmonary fibrosis (IPF) with percent predicted forced vital capacity (FVC)<50% treated with pirfenidone (PFD) in RECAP
    Costabel, Ulrich
    Albera, Carlo
    Kirchgaessler, Klaus-Uwe
    Gilberg, Frank
    Petzinger, Ute
    Noble, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [9] ANNUAL RATE OF FVC DECLINE IN PATIENTS WITH IPF TREATED WITH PIRFENIDONE: POOLED ANALYSIS (ENCORE)
    Noble, Paul W.
    Albera, Carlo
    Chou, Willis
    Costabel, Ulrich
    Day, Bann-Mo
    Glaspole, Ian
    Glassberg, Marilyn K.
    Lancaster, Lisa
    Lederer, David J.
    Nathan, Steven D.
    Pereira, Carlos A.
    Stauffer, John
    Swigris, Jeffrey J.
    RESPIROLOGY, 2017, 22 : 79 - 79
  • [10] Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone
    Kono, Masato
    Nakamura, Yutaro
    Enomoto, Noriyuki
    Saito, Go
    Koyanagi, Yu
    Miyashita, Koichi
    Tsutsumi, Akari
    Kobayashi, Takeshi
    Yasui, Hideki
    Hozumi, Hironao
    Karayama, Masato
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Miki, Yoshihiro
    Hashimoto, Dai
    Fujisawa, Tomoyuki
    Inui, Naoki
    Suda, Takafumi
    Nakamura, Hidenori
    RESPIRATORY INVESTIGATION, 2019, 57 (06) : 552 - 560
12345